Kits Eyecare (TSE:KITS – Get Free Report) had its target price reduced by Canaccord Genuity Group from C$23.00 to C$22.00 in a report issued on Thursday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 92.48% from the stock’s current price.
Several other brokerages have also recently weighed in on KITS. Desjardins dropped their target price on Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating for the company in a report on Thursday. Stifel Nicolaus lowered their price objective on Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating for the company in a research report on Thursday. Finally, ATB Cormark Capital Markets dropped their price objective on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating for the company in a research note on Thursday. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of C$20.69.
Check Out Our Latest Stock Analysis on KITS
Kits Eyecare Stock Down 7.7%
Kits Eyecare (TSE:KITS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported C$0.06 earnings per share (EPS) for the quarter. The company had revenue of C$57.47 million for the quarter.
Kits Eyecare Company Profile
KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.
Further Reading
Receive News & Ratings for Kits Eyecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kits Eyecare and related companies with MarketBeat.com's FREE daily email newsletter.
